CLASSYS Inc (214150.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea
CLASSYS Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 242.94 bn KRW | 336.82 bn KRW |
| Gross profit | 191.13 bn KRW | 261.09 bn KRW |
| Operating income | 110.75 bn KRW | 170.60 bn KRW |
| EBIT | 129.97 bn KRW | 171.05 bn KRW |
| Net income | 97.88 bn KRW | 131.94 bn KRW |
| Diluted EPS – continuing operations | 1,494.24 KRW | 2,019.42 KRW |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CLASSYS Inc
CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue; Secret RF, a device that delivers radio frequency energy into the skin; Secret PRO, a multiple fractional device that delivers micro-level laser beams fractionally to the tissue; Secret DUO, a multi-functional device that delivers high-frequency energy through needle electrodes; and Fortra, a 4 wavelengths diode laser. It also provides SCIZER and CLATUU Alpha for non-invasive subcutaneous fat reduction; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE, a combination of four handpieces used for acne suction, muscle pain relief, and other pain relief; FORSHAPE, an RF treatment system used to increase metabolism, blood circulation, and tissue recovery; and INTRASURE for lifting, wrinkle reduction, body contouring, and cellulite reduction. In addition, the company offers AQUAPURE II, which exfoliates hyper-keratinized dead skin cells; Reepot, a medical device that delivers energy to tissue; veloce, which enhances treatment results; Pento, a laser surgical device for tissue incision, destruction, and removal; and curas hybrid laser system. Further, it sells cosmetics. The company offers its products under the Classys, Cluederm, and Skederm brands. It serves distributors, clinics, hospitals, and direct end users. The company was founded in 2007 and is headquartered in Seoul, South Korea. CLASSYS Inc. is a subsidiary of BCPE Centur Investments, LP.
More stocks
- TeamViewer (TMV.DE)
- Taysha Gene Therapies, Inc. (TSHA)
- GOODYEAR TIRE & RUBBER CO /OH/ (GT)
- Precision Drilling Corporation(Calgary) (PD.TO)
- Hefei Metalforming Mach Tool (603011.SS)
- Hopson Development Holdings Ltd (754.HK)
- Viel et Compagnie SA (VIL.PA)
- Dole plc (DOLE)
- AMERICAN SUPERCONDUCTOR CORP /DE/ (AMSC)
- Guangdong Yizumi Precision Machinery Co Ltd (300415.SZ)
- Jiangyin Jianghua Microelectronics Materials Co Ltd (603078.SS)
- Dongguan Tarry Electronics Co.Ltd (300976.SZ)
Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.